Tulobuterol Hydrochloride

• CAT Number: R021113
• CAS Number: 56776-01-3
• Molecular Formula: C12H19Cl2NO
• Molecular Weight: 264.19
• Purity: ≥95%
• Synonyms: 2-Chloro-α-[[(1,1-dimethylethyl)amino]methyl]benzenemethanol Hydrochloride; (+/-)-Tulobuterol Hydrochloride; HN 078; o-Chloro-α-[(tert-butylamino)methyl]benzyl Alcohol Hydrochloride
• Target: Neuronal Signaling
• Storage: 2-8°C
• IUPAC Name: 2-(tert-butylamino)-1-(2-chlorophenyl)ethanol;hydrochloride
• InChI: InChI=1S/C12H18ClNO.ClH/c1-12(2,3)14-8-11(15)9-6-4-5-7-10(9)13;/h4-7,11,14-15H,8H2,1-3H3;1H
• InChIKey: RSLNRVYIRDVHLY-UHFFFAOYSA-N
• SMILES: CC(C)(C)NCC(C1=CC=CC=C1Cl)O.Cl

Tulobuterol Hydrochloride（Cat No.:R021113）is a long-acting β2-adrenergic receptor agonist (LABA) used primarily for managing asthma and chronic obstructive pulmonary disease (COPD). By stimulating β2-receptors in the bronchial muscles, Tulobuterol Hydrochloride induces bronchodilation, easing airway constriction and improving airflow in patients with respiratory disorders. Its long duration of action allows for sustained symptom control, making it effective for both chronic management and acute exacerbations. Tulobuterol Hydrochloride is commonly administered via transdermal patches, offering a convenient and consistent release of the drug for optimal therapeutic benefits in respiratory care.